m
Recent Posts
Connect with:
Monday / May 10.
HomemieducationSame, Same, but Different: Why Fluid Location Matters in nAMD

Same, Same, but Different: Why Fluid Location Matters in nAMD

The introduction of intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy two decades ago, heralded a paradigm shift in the treatment of neovascular age-related macular degeneration (nAMD). Clinical trials have consistently shown a mean functional improvement of +6.5 to +10.5 letter visual gain, with six to 13 injections required over 12 months, depending on the treatment regimen followed.1–3 Similarly, there is a reduction in central retinal thickness (CRT) and decreased exudation of fluid on opticalcoherence tomography (OCT) scans following anti-VEGF therapy…Read and Take Test

DECLARATION

DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.